Navigation Links
joimax(R) Holds the First International TESSYS(R) User Meeting in Veenhuizen, The Netherlands, and Announces the Launch of Various New Products for Endoscopic Spinal Surgery
Date:5/14/2010

KARLSRUHE, Germany, May 14, 2010 /PRNewswire/ -- On 14 and 15 May 2010 joimax(R) GmbH holds the first international user meeting of endoscopic spinal surgery in Veenhuizen/Niederlande. Besides the ten reference surgeons about 30 participants and customers from Germany, Europe, the United States and other countries are expected to join the meeting. The scientific program comprises a two-day conference which will be opened with a keynote lecture of Prof. Dr. Gerbrand J. Groen of the university of Utrecht. CEO and founder of the company Wolfgang Ries will give an outline of the product offensive in the coming months in the field of access systems, ablation and drilling systems and the latest joimax(R) HD technologies.

One of the highlights of this event will be the opening ceremony of Rugkliniek Iprenburg in Veenhuizen. The head of this private clinic Dr. Menno Iprenburg, a long-time member of the joimax(R) Faculty, having completed more than 900 TESSYS(R) surgeries, states: "It was the right decision to give up my position as chief surgeon in Assen and to risk once again total self-employment with the joimax(R) TESSYS(R) method," and, "this is also proven by the significantly increasing number of patients and the possibility of operating more indications with the joimax(R) endoscopic methods."

For further information please visit http://www.joimax.com.

About joimax:

The young medical devices company is focusing on combined minimal access technologies ("joined minimal access technologies"), especially for spinal treatment. joimax(R) develops, manufactures and markets as unique player highly sophisticated and user friendly platform systems for endoscopic spinal surgery, which are evolving by experience and which are well evaluated to succeed. Due to education and multi-year business experience of its employees joimax(R) has gained core competencies in medical devices, systems, hard- and software, instruments, endoscopes, disposables and implants. It also offers a well thought-out education program that comprises three steps: Firstly attending a workshop, then a visitation at one of the reference centres and finally conducting first own surgeries together with experienced application specialists.

    Contact:

    joimax(R) GmbH
    Pia Kusterer, Marketing Coordinator
    An der Raumfabrik 33a, Amalienbadstr. 36
    D-76227 Karlsruhe
    phone: +49-721-255-14-516
    fax: +49-721-255-14-920
    email: pia.kusterer@joimax.com



'/>"/>
SOURCE joimax GmbH
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Calcitech Holds Annual General Meeting
2. New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C
3. U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
4. New Treatment for Autism Holds Promise
5. New Australian Drug Holds Hope of Major Breakthrough in Treating Terminal Blood Cancers
6. Nephros Reports 2010 First Quarter Financial Results
7. Octapharma USA Announces Availability and Distributors for wilate®, the First Replacement Therapy Developed Specifically for von Willebrand Disease
8. Karmanos Cancer Center Surgeon is Michigans First to Perform Transoral Robotic Surgery on Patients
9. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET
10. China Nepstar Chain Drugstore Reschedules First Quarter 2010 Results to May 18
11. WuXi PharmaTech Announces First-Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)...   TyrNovo , s NT219 ... cancer drug resistance and would ...   NT219 is a novel proprietary ... oncogenic pathways ( IRS1/2 and STAT3) highly ... the tumor .   NT219 has ...
(Date:1/12/2017)... 2017 This new report from VPGMarketResearch contains ... of the German hospital microbiology testing market, including:  ... hospital laboratory practice, as well as key economic, regulatory, ... during the next ten years.  ... and etiology of major infectious diseases and microorganisms.  ...
(Date:1/12/2017)... -- Harrington Discovery Institute at University Hospitals in ... Drug Discovery Foundation (ADDF) have expanded their collaboration ... Alzheimer,s disease. Together, the two organizations will jointly ... academic researchers. By leveraging their combined expertise, investment, ... will advance Alzheimer,s disease drug discovery projects of ...
Breaking Medicine Technology:
(Date:1/15/2017)... ... January 15, 2017 , ... The JPR Group, a ... announce that it will be assisting HackensackUMC Mountainside with its public relations efforts, ... servicing all surrounding towns. The firm will be working closely with HackensackUMC Mountainside’s ...
(Date:1/14/2017)... ... January 14, 2017 , ... "TransFreeze Volume 3 is a self animating masking transition which ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... frame transition from one clip to the next. , To use “Cut-Out First” ...
(Date:1/13/2017)... NJ (PRWEB) , ... January 13, 2017 , ... ... sale companions, will be showcasing the next generation companion scanner and data collector at ... The new KDC270 has been created as an answer to the market’s need for ...
(Date:1/13/2017)... ... January 13, 2017 , ... People who have sensitive teeth are about ... they brush their teeth. Sadly, most dental hygiene products in the market contain chemical ... For these people, continuing their daily oral care routine to keep their teeth white ...
(Date:1/13/2017)... ... 2017 , ... MyGenetx, a molecular laboratory headquartered in middle Tennessee is proud ... Smith, RD, LD, will serve on the 2017 TBCC Board. , Kris ... and one year as Vice President. She will oversee the newly elected board of ...
Breaking Medicine News(10 mins):